A PHARMACOGENETIC STUDY OF ALDEHYDE OXIDASE I IN PATIENTS TREATED WITH XK469

XK469 (NSC 697887) is a selective topoisomerase II β inhibitor eliminated mainly via aldehyde oxidase I (AOX1). We performed a candidate gene study to investigate whether AOX1 genetic variation contributes to interindividual variability in XK469 clearance. Forty-one AOX1 single nucleotide polymorphi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Ramírez, Jacqueline, Kim, Tae Won, Liu, Wanqing, Myers, Jamie L., Mirkov, Snezana, Owzar, Kouros, Watson, Dorothy, Mulkey, Flora, Gamazon, Eric R., Stock, Wendy, Undevia, Samir, Innocenti, Federico, Ratain, Mark J.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3901533/
https://ncbi.nlm.nih.gov/pubmed/24300566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0000000000000023
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items